International Journal of Clinical Research

Objective To explore the value of cefoperazone sulbactam combined with ambroxol hydrochloride in the treatment of chronic obstructive pulmonary disease. Methods A total of 96 patients with chronic obstructive pulmonary disease admitted to our hospital were selected and randomly divided into 2 groups, with 48 cases in each group. The control group was treated with cefoperazone sulbactam, while the observation group was treated with cefoperazone sulbactam combined with ambroxol hydrochloride. Compare the therapeutic effects of the two groups. Results After treatment, the FVC and FEV1 in the observation group increased compared with those in the control group, while the CAT and mMRC scores decreased compared with those in the control group (P < 0.05). Conclusion The treatment effect of cefoperazone sulbactam combined with ambroxol hydrochloride for chronic obstructive pulmonary disease is better.

Chronic obstructive pulmonary disease; Cefoperazone sulbactam; Ambroxol hydrochloride